Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:LGNZZ
DateTimeSourceHeadlineSymbolCompany
3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
05/13/20246:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/13/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/09/20246:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/09/20246:03PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/08/20244:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/07/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/07/20247:36AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
06/05/20204:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/08/20204:29PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/06/20204:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/24/20207:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/24/20207:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/24/20207:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/24/20204:10PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/24/20204:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/07/20204:41PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/06/20205:16PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
04/02/20204:19PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
03/13/20206:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/27/20205:38PMEdgar (US Regulatory)Annual Report (10-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/18/20205:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/18/20205:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/18/20205:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/18/20205:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/14/20201:19PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/14/202011:34AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/14/202010:04AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/14/20207:45AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/13/202011:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
 Showing the most relevant articles for your search:USOTC:LGNZZ